Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
March 21, 2024 16:05 ET | Hyperfine, Inc.
GUILFORD, Conn., March 21, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Reports Third Quarter 2023 Financial Results
November 09, 2023 16:05 ET | Hyperfine, Inc.
GUILFORD, Conn., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared,...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Reports Second Quarter 2023 Financial Results
August 14, 2023 16:05 ET | Hyperfine, Inc.
GUILFORD, Conn., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable,...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Reports First Quarter 2023 Financial Results
May 11, 2023 16:05 ET | Hyperfine, Inc.
GUILFORD, Conn., May 11, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable,...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. to Announce First Quarter Financial Results on May 11, 2023
April 20, 2023 16:05 ET | Hyperfine, Inc.
GUILFORD, Conn., April 20, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results
March 21, 2023 16:05 ET | Hyperfine, Inc.
GUILFORD, Conn., March 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
March 06, 2023 08:55 ET | Hyperfine, Inc.
GUILFORD, Conn., March 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Receives FDA Clearance for Updated Software to Further Improve Diffusion-Weighted Imaging
February 28, 2023 08:55 ET | Hyperfine, Inc.
GUILFORD, Conn., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Swoop® Portable MR Imaging® System Receives CE Marking After Meeting Comprehensive New EU MDR Regulations
February 21, 2023 08:55 ET | Hyperfine, Inc.
GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop® system, the world's first FDA-cleared portable...
Hyperfine_Trademarked Logo .png
Hyperfine, Inc. Announces FDA Clearance for Improved AI-Powered Software and Expanded Field of View for the Swoop® Portable MR Imaging® System
February 13, 2023 08:55 ET | Hyperfine, Inc.
GUILFORD, Conn., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc., the groundbreaking medical device company that created the Swoop® system, the world’s first FDA-cleared portable magnetic...